tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Sarepta Therapeutics (SRPT)
NASDAQ:SRPT
US Market
SRPT
Sarepta Therapeutics
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Advertisement

Sarepta Therapeutics (SRPT) Stock News & Sentiment

Compare
3,729 Followers
Top 3 Trending Stocks, According to Analysts – 7/18/2025
Premium
Market News
Top 3 Trending Stocks, According to Analysts – 7/18/2025
3h ago
ABT
NFLX
Cautious Outlook on Sarepta Therapeutics Amid Transparency and Safety Concerns
Premium
Ratings
Cautious Outlook on Sarepta Therapeutics Amid Transparency and Safety Concerns
10h ago
SRPT
Sarepta Stock (SRPT) Crashes 37% as FDA Scrutiny Mounts Over Gene Therapy Deaths
Premium
Market News
Sarepta Stock (SRPT) Crashes 37% as FDA Scrutiny Mounts Over Gene Therapy Deaths
10h ago
SRPT
Positive Outlook for Sarepta Therapeutics Amid Strategic Reorganization and Risk Mitigation
Premium
Ratings
Positive Outlook for Sarepta Therapeutics Amid Strategic Reorganization and Risk Mitigation
18h ago
SRPT
Positive Outlook for Sarepta Therapeutics Amid Strategic Developments and Cost Management
Premium
Ratings
Positive Outlook for Sarepta Therapeutics Amid Strategic Developments and Cost Management
2d ago
SRPT
Sarepta Therapeutics Faces Sell Rating Amid Declining ELEVIDYS Revenues and Market Challenges
Premium
Ratings
Sarepta Therapeutics Faces Sell Rating Amid Declining ELEVIDYS Revenues and Market Challenges
2d ago
SRPT
Positive Outlook for Sarepta Therapeutics Amid Strategic Restructuring and Regulatory Resolution
Premium
Ratings
Positive Outlook for Sarepta Therapeutics Amid Strategic Restructuring and Regulatory Resolution
2d ago
SRPT
More SRPT News >

SRPT News on the Web

Major biotech stock tumbles 35 percent after major rare disease setback
TheStreet.com
Neutral
Sarepta Therapeutics (SRPT) was downgraded to a Hold Rating at Needham
TipRanks News
Neutral
Sarepta shares sink on third gene therapy-linked death
Proactive Investors
Neutral
Another liver toxicity death adds to Sarepta concerns, says Morgan Stanley
The Fly
Neutral
Sarepta not disclosing death 'deeply troubling,' says Leerink
The Fly
Neutral
Sarepta patient death could bring greater scrutiny, says William Blair
The Fly
Neutral
Why Sarepta Therapeutics, Inc.’s (SRPT) Stock Is Down 15.95%
AAII
Neutral
Sarepta shares soar on restructuring, R&D refocus
Proactive Investors
Neutral

News Score - Last 7 Days

Neutral
SRPT
Sector Average
Media Buzz
This Week24 articles
Weekly Average8.25 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SRPT’s Media Buzz Sentiment?
24 articles about SRPT were published this week. In an average week, 8.25 articles are published.
    What is SRPT’s weekly average amount of articles?
    In an average week, 8.25 articles about SRPT are published.
      What is SRPT’s News Sentiment?
      50% of articles about SRPT were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        NEVIPascal Biosciences Inc
        JNJJohnson & Johnson
        HRMYHarmony Biosciences Holdings
        ABTAbbott Laboratories
        WATWaters
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing